Safety of Voriconazole in a Patient with CYP2C9*2/CYP2C9*2 Genotype-Reference-Cited by-同舟云学术

Safety of Voriconazole in a Patient with CYP2C9*2/CYP2C9*2 Genotype

Published:2006-09 Issue:9 Volume:50 Page:3227-3228
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Geist Marcus J.P.¹,Egerer Gerlinde²,Burhenne Jürgen¹,Mikus Gerd¹

Affiliation:

1. Department of Internal Medicine VI  Clinical Pharmacology and Pharmacoepidemiology  University of Heidelberg  Im Neuenheimer Feld 410  D-69120 Heidelberg, Germany

2. Department of Internal Medicine V  Haematology, Oncology and Rheumatology  University of Heidelberg  Im Neuenheimer Feld 410  D-69120 Heidelberg, Germany

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00551-06

Reference10 articles.

1. Burian, M., S. Grosch, I. Tegeder, and G. Geisslinger. 2002. Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German population. Br. J. Clin. Pharmacol.54:518-521.

2. Hyland, R., B. C. Jones, and D. A. Smith. 2003. Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole. Drug Metab. Dispos.31:540-547.

3. Lee, C. R., J. A. Goldstein, and J. A. Pieper. 2002. Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics12:251-263.

4. Clin. Pharmacol. Ther.

5. Development and Validation of a High-Performance Liquid Chromatography Assay for Voriconazole

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CYP2C19, CYP2C9, CYP3A4, and FMO3 Genetic Polymorphisms and Sex on the Pharmacokinetics of Voriconazole after Single and Multiple Doses in Healthy Chinese Subjects;The Journal of Clinical Pharmacology;2024-04-23

2. Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?;Expert Review of Clinical Pharmacology;2024-02-21

3. Recommendations on the use of azole antifungals in hematology-oncology patients;Revista Española de Quimioterapia;2023-04-05

4. Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism;Pharmaceutics;2022-02-22

5. Effects of CYP2C19, CYP2C9 and CYP3A4 gene polymorphisms on plasma voriconazole levels in Chinese pediatric patients;Pharmacogenetics and Genomics;2022-01-25